ASIC

The ASIC Rewrite took effect on 21 October 2024, when the ASIC Derivative Transaction Rules (Reporting) 2024 replaced the 2022 rules. The Rewrite aligned Australian OTC derivative reporting with global standards: ISO 20022 XML messaging, the UTI, the UPI and harmonised critical data elements (CDE). Singapore's MAS implemented its equivalent revised reporting requirements on the same date, allowing firms in both jurisdictions to upgrade once. A smaller second tranche of ASIC rule changes follows in October 2025.

Reporting entities under the ASIC rules include Australian financial services licensees, Australian ADIs (banks), CS facility licensees, and certain foreign entities such as foreign ADIs with an Australian branch. In-scope entities must report their OTC derivative transactions and positions in interest rate, FX, credit, equity and commodity (non-electricity) asset classes. Exchange-traded derivatives on licensed markets are outside the OTC regime.

OTC derivative transactions must be reported by T+1 — the end of the business day following execution, modification or termination. Lifecycle events and valuation and collateral updates follow the same next-day standard. Reports are submitted to a licensed Australian derivative trade repository in ISO 20022 XML, and rejected submissions must be corrected and resubmitted promptly to keep the entity's reporting complete.

Yes — a reporting entity may appoint a delegate, such as its counterparty, a broker or a third-party provider, to submit reports on its behalf. The ASIC rules include a safe-harbour provision: the entity is taken to have complied if it has a legally binding delegation agreement and takes reasonable steps, including regular checks, to ensure the delegate is reporting correctly. Responsibility for the obligation itself remains with the reporting entity.

DTCC Data Repository (Singapore) Pte Ltd (DDRS) is the licensed Australian derivative trade repository used for ASIC OTC derivative reporting. Reporting entities submit their transaction, valuation and collateral reports to DDRS in ISO 20022 XML, and DDRS applies ASIC's validation rules, rejecting non-conforming submissions. Firms should verify current licensing on ASIC's derivative trade repository register.

Yes — since the Rewrite on 21 October 2024, ASIC reports must carry a Unique Transaction Identifier (UTI), generated and shared according to the international UTI waterfall, and a Unique Product Identifier (UPI) issued by ANNA-DSB for OTC derivative products. These replace the previous mix of trade identifiers and product taxonomies, and align ASIC reports with the CFTC, EU and UK regimes — simplifying multi-jurisdiction reporting for globally active firms.

Both regimes require T+1 reporting of OTC derivatives with UTI, UPI and ISO 20022 XML, but they differ in structure. ASIC reporting is effectively single-sided in many cases through delegation and its safe harbour, covers OTC derivatives only, and uses one licensed trade repository. EMIR is strictly two-sided with TR reconciliation, covers exchange-traded derivatives as well, and offers a choice of trade repositories. Field sets overlap heavily through CDE but are not identical.

Alternative reporting — the pre-Rewrite mechanism that let certain foreign entities satisfy ASIC obligations by reporting under an equivalent foreign regime tagged for ASIC — was phased out under the 2024 rules. Foreign reporting entities now generally report under the ASIC rules themselves, directly or through a delegate. Firms that previously relied on alternative reporting should confirm their current obligations against the ASIC Derivative Transaction Rules (Reporting) 2024.